Alex Sankin

818 total citations
21 papers, 378 citations indexed

About

Alex Sankin is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Alex Sankin has authored 21 papers receiving a total of 378 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Surgery, 10 papers in Pulmonary and Respiratory Medicine and 5 papers in Oncology. Recurrent topics in Alex Sankin's work include Bladder and Urothelial Cancer Treatments (8 papers), Prostate Cancer Diagnosis and Treatment (8 papers) and Prostate Cancer Treatment and Research (7 papers). Alex Sankin is often cited by papers focused on Bladder and Urothelial Cancer Treatments (8 papers), Prostate Cancer Diagnosis and Treatment (8 papers) and Prostate Cancer Treatment and Research (7 papers). Alex Sankin collaborates with scholars based in United States and United Kingdom. Alex Sankin's co-authors include Herbert Lepor, Guilherme Godoy, Tracy Marien, Patrick Mufarrij, Basir Tareen, Samir S. Taneja, Evan Kovac, Ahmed Aboumohamed, Kara Watts and Trinity J. Bivalacqua and has published in prestigious journals such as The Journal of Urology, Urology and British Journal of Urology.

In The Last Decade

Alex Sankin

19 papers receiving 368 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alex Sankin United States 12 261 139 83 54 52 21 378
Vito Lacetera Italy 11 177 0.7× 79 0.6× 118 1.4× 27 0.5× 87 1.7× 38 324
Hodo Haxhimolla Australia 9 252 1.0× 115 0.8× 82 1.0× 92 1.7× 53 1.0× 23 364
Wagner Eduardo Matheus Brazil 13 214 0.8× 134 1.0× 80 1.0× 27 0.5× 83 1.6× 41 361
Georges Mjaess Lebanon 9 76 0.3× 95 0.7× 43 0.5× 44 0.8× 49 0.9× 51 337
Richard Lockyer United Kingdom 5 204 0.8× 91 0.7× 24 0.3× 60 1.1× 36 0.7× 5 301
Jin Seon Cho South Korea 12 370 1.4× 97 0.7× 159 1.9× 16 0.3× 180 3.5× 67 507
Michael Daugherty United States 12 167 0.6× 166 1.2× 41 0.5× 22 0.4× 92 1.8× 39 364
Răzvan Bardan Romania 11 102 0.4× 50 0.4× 35 0.4× 27 0.5× 39 0.8× 51 296
Yuma Waseda Japan 12 158 0.6× 214 1.5× 20 0.2× 98 1.8× 67 1.3× 56 394
Ahmed Aboumohamed United States 10 151 0.6× 220 1.6× 32 0.4× 23 0.4× 113 2.2× 32 392

Countries citing papers authored by Alex Sankin

Since Specialization
Citations

This map shows the geographic impact of Alex Sankin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alex Sankin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alex Sankin more than expected).

Fields of papers citing papers by Alex Sankin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alex Sankin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alex Sankin. The network helps show where Alex Sankin may publish in the future.

Co-authorship network of co-authors of Alex Sankin

This figure shows the co-authorship network connecting the top 25 collaborators of Alex Sankin. A scholar is included among the top collaborators of Alex Sankin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alex Sankin. Alex Sankin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhu, Michael X., Erin Ohmann, Melissa Laudano, et al.. (2024). Health-related Internet Use Among New Urology Clinic Patients. Urology. 194. 1–6. 2 indexed citations
2.
Sankin, Alex, Rebecca H. Boucher, Maurice P. Zeegers, et al.. (2024). Low-grade Urothelial Carcinoma Recurs at a Tempo that Naturally Accelerates Over Time. Urology. 193. 166–172.
3.
Inman, Brant A., Noah M. Hahn, Kelly Stratton, et al.. (2023). A Phase 1b/2 Study of Atezolizumab with or Without Bacille Calmette-Guérin in Patients with High-risk Non–muscle-invasive Bladder Cancer. European Urology Oncology. 6(3). 313–320. 21 indexed citations
4.
Zhu, Denzel, Justin Loloi, Kara Watts, et al.. (2023). Low risk is low risk, regardless of race or ethnicity: Outcomes of prostate cancer active surveillance and factors associated with reclassification in a racially diverse cohort. Urologic Oncology Seminars and Original Investigations. 41(4). 204.e7–204.e15.
6.
Abramson, Max, Juyoung Park, Evan Kovac, et al.. (2022). Urine Cytology Rarely Escalates Clinical Management in the Surveillance of Non–muscle-Invasive Bladder Cancer. Clinical Genitourinary Cancer. 21(2). 258–264. 4 indexed citations
7.
8.
Zhu, Denzel, Justin Loloi, Deborah E. Schwartz, et al.. (2022). Clinical Risk Factors Associated With Small Renal Mass Malignant Histology in a Multi-Ethnic Population Undergoing Partial Nephrectomy. Clinical Genitourinary Cancer. 20(6). e465–e472. 3 indexed citations
10.
Zhu, Denzel, Victoria Chernyak, Evan Kovac, et al.. (2021). A Comparison of Image-Guided Targeted Prostate Biopsy Outcomes by PI-RADS® Score and Ethnicity in a Diverse, Multiethnic Population. The Journal of Urology. 206(3). 586–594. 6 indexed citations
11.
Watts, Kara, et al.. (2020). Systematic review and meta-analysis comparing cognitive vs. image-guided fusion prostate biopsy for the detection of prostate cancer. Urologic Oncology Seminars and Original Investigations. 38(9). 734.e19–734.e25. 43 indexed citations
12.
Daniels, Marcus J., et al.. (2019). An evaluation of monthly maintenance therapy among patients receiving intravesical combination gemcitabine/docetaxel for nonmuscle-invasive bladder cancer. Urologic Oncology Seminars and Original Investigations. 38(2). 40.e17–40.e24. 21 indexed citations
13.
Daniels, Marcus J., Mark Schoenberg, Donald L. Lamm, et al.. (2019). Contemporary oncologic outcomes of second induction course BCG in patients with nonmuscle invasive bladder cancer. Urologic Oncology Seminars and Original Investigations. 38(1). 5.e9–5.e16. 12 indexed citations
14.
Sun, Yue, Victor E. Reuter, Cristina Magi‐Galluzzi, Alex Sankin, & Jonathan I. Epstein. (2018). Granular Cell Tumor of the Bladder: A Report of Six Cases. Urology. 121. 203.e1–203.e5. 5 indexed citations
15.
Mufarrij, Patrick, Alex Sankin, Guilherme Godoy, & Herbert Lepor. (2010). Pathologic Outcomes of Candidates for Active Surveillance Undergoing Radical Prostatectomy. Urology. 76(3). 689–692. 71 indexed citations
16.
Tareen, Basir, et al.. (2009). Can contemporary transrectal prostate biopsy accurately select candidates for hemi‐ablative focal therapy of prostate cancer?. British Journal of Urology. 104(2). 195–199. 37 indexed citations
17.
Marien, Tracy, Alex Sankin, & Herbert Lepor. (2009). Factors Predicting Preservation of Erectile Function in Men Undergoing Open Radical Retropubic Prostatectomy. The Journal of Urology. 181(4). 1817–1822. 54 indexed citations
20.
Clark, Timothy W.I., et al.. (2007). Stent-Assisted Gugliemi Detachable Coil Repair of Wide-Necked Renal Artery Aneurysm Using 3-D Angiography. Vascular and Endovascular Surgery. 41(6). 528–532. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026